Eli Lilly

Pharma

FDA approves Lilly's Mounjaro to reduce risk of cardio events

The FDA has signed off on a label expansion for Eli Lilly's Mounjaro to reduce the risk of heart attack or stroke in at-risk adults with type 2 diabetes.

Kevin Dunleavy Aug 28, 2026 10:52am

showdown clash versus vs crash lightning fight dispute

The Oral GLP-1 Tracker: Lilly's Foundayo scripts cross 40K

Aug 28, 2026 9:30am

BMS to build $173M radiopharmaceutical plant in Indiana

Aug 27, 2026 2:45pm

Lilly covers aging and obesity in new GLP-1 access campaign

Aug 24, 2026 4:02pm

UK cost watchdog endorses Lilly's weekly insulin injectable

Aug 20, 2026 9:12am

Novo testing smaller doses of Wegovy pill in phase 3 study

Aug 20, 2026 8:51am